Promising
Modafinil
The prediction game
Call it: rising or fading?
Where does Modafinil stand 12 months from now? Lock your call with a confidence level. When the window closes, the Brier rule scores your calibration: right and confident earns the most, wrong and confident costs the most. Points and a leaderboard spot are the whole prize. No stakes, no money.
One call per intervention. It locks the moment you submit: no edits, no cancels. It resolves when the 12-month window closes.
The Crowd’s Call
Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.
Community Signal
No weigh-ins yet. Be the first and set the early signal.
Evidence
Evidence grade: B (good evidence)
Graded from the strength of the published research, independent of any verdict on this page.
Evidence Anchor
BioHarmony 5.9/10
Modafinil is a 5.9 / 10 fit for people using cognition focus, energy, and mood as a measured experiment, not a belief-based staple. The best anchors are [Caldwell JA et al. 2004](https://pubmed.ncbi.nlm.nih.gov/15460629/), which reports pilot performance and mood study during extended wakefulness and relevant to sleep-deprivation rescue rather than rested daily enhancement, and [Muller U et al. 2013](https://pubmed.ncbi.nlm.nih.gov/22820554/), which reports healthy-volunteer study supporting a mixed cognitive profile and creativity trade-off rather than uniform enhancement. That gives Modafinil a real signal, but the report should stay narrow because responder fit, baseline status, and outcome tracking drive the practical value. Use Modafinil when the target is specific, measurable, and worth the tradeoff. Skip or stop Modafinil when the expected symptom, lab, or performance marker stays flat. ✅ Best for: Adults with diagnosed narcolepsy or idiopathic hypersomnia working with a sleep clinician; OSA patients with residual sleepiness after airway treatment; shift-work patients using modafinil as part of a circadian plan; and selective off-label users who need infrequent travel, jet lag, or sleep-debt rescue. Modafinil is also a fit for narrow, convergent work where wakefulness is the bottleneck and the dose can be taken early. The cleanest personal-use pattern is low-dose, intermittent, morning-only use with caffeine reduced or removed. ❌ Avoid if: You are pregnant, planning conception, or relying on hormonal contraception without backup; you have a history of serious drug rash, SJS/TEN, DRESS, mania, psychosis, uncontrolled anxiety, arrhythmia, structural heart disease, or stimulant sensitivity; you take MAOIs or complex CYP-interacting medication stacks; you are a tested athlete without anti-doping review; or you want daily motivation in place of sleep. Avoid chronic daily off-label nootropic use, unverified gray-market sourcing, pediatric use, and late-morning or afternoon dosing.
Read the full BioHarmony report
My score and my verdict: one signal of three, never the whole answer.
Momentum
Signals begin with Edition 2
Direction needs two weekly snapshots to compare, so the arrows stay off until the next edition. Attention tracking is already running.
Momentum = how fast attention is rising across search, Reddit, PubMed, podcasts, and curated industry newsletters this week; it can flag an item as Overhyped/Fading, but it never overrides the evidence behind Proven. How momentum works.
- Ring
- Promising
- Trend
- Begins with Edition 2
- Momentum
- 5.3%
- BioHarmony Score
- 5.9/10
- Last Updated
- Jul 2, 2026
Sources
- BioHarmony score
- Search trend delta
- Reddit velocity
- PubMed publication count
- Podcast mention frequency
- Curated newsletter mentions
The score anchors the ring; the other five drive momentum, which can nudge the ring by one step at most. How placement works.
Weigh In
Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.